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Development of consultant
pharmacy in the USA
Consultant pharmacy developed
from community pharmacy practice.
Those based in community practice
were providing a medication supply
service to nursing homes with a number
of these practitioners providing a more
advanced service than basic dispensing.
Legislation in the mid-1960’s sought to
improve the quality of nursing home
care, but perhaps the most important
development in nursing home
regulation and legislation was the
publication of the Institute of
Medicine’s (IOM) report on improving
the quality of care in nursing homes in
19861.
One of the key recommendations
from the report was that: “each
resident is to receive high-quality care
to meet individual physical, mental and
psychosocial needs.  The care should be
designed to maintain or improve the
residents’ physical, mental, and
emotional well-being”.1
The Omnibus Budget
Reconciliation Act of 1987
(OBRA 87)
Following the IOM report,
legislation was enacted within the USA
to improve care in nursing homes - the
Nursing Home Reform Act which was
embedded in the Omnibus Budget
Reconciliation Act of 1987 (OBRA 87)2
- and was implemented in October
1991.
As a first step to improve the
quality of care in nursing homes,
attempts have been made through the
OBRA regulations to undertake a
comprehensive assessment of the
residents’ needs, encompassing the
following areas:
• Medically defined conditions and
prior medical history
• Medical status measurement
• Functional status
• Sensory and physical impairments
• Nutritional status and requirements
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Consultant pharmacy represents a branch of the profession
that has almost become synonymous with nursing homes in
the USA.  This is largely due to the legal framework that
surrounds nursing home care in the USA and the requirement
for pharmacy review of medication in this setting.  However,
consultant pharmacy has been in existence for almost 30
years and had its roots in community practice; today, a
consultant pharmacist is defined as a practitioner who
provides services to long-term care facilities on a contractual
basis.  This paper provides an overview of this type of
pharmacy practice, the current delivery of consultant
pharmacy services in the USA and lessons for the
international pharmacy profession.
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• Special treatments or procedures
• Psychosocial status
• Discharge potential
• Dental condition
• Activities potential
• Rehabilitation potential
• Cognitive status
• Drug therapy
Such assessments must be carried
out on patients no later than 14 days
after admission, following a significant
change in the resident’s physical or
mental condition and at least once
every 12 months, with a partial
reassessment every quarter.
As a means to assist in this
standardisation of care, it was
necessary to develop an instrument
which could be used in the collection
of patient data.  The Resident
Assessment Instrument (RAI) was
produced by a research consortium in
conjunction with the federal
organisation that oversees the US
government’s health programmes-the
Health Care Financing Agency (HCFA)3.
It includes a set of central assessment
items known as the Minimum Data Set
(MDS) and 18 Resident Assessment
Protocols (RAPs).
In terms of prescribing, the MDS
contains a domain which embraces
medication use; this specifically relates
to the following elements:
• the number of medications used in
the previous 7 days
• if any new medications had been
initiated in the previous 90 days
• the number of days during which
the resident had received injections
of any kind in the previous 7 days
• the number of days (during the last
7 days) the resident received an
antipsychotic, anxiolytic,
antidepressant, hypnotic or diuretic
medication.
Drug Regimen Review (DRR) is the
means by which drug therapy in
patients is evaluated in most long-term
care facilities.  Such reviews, under
current legislation, are carried out on a
monthly or quarterly basis by a
consultant pharmacist.
The DRR should include at least an
evaluation of the appropriateness of,
and response to, each patient’s drug
therapy.  The pharmacist must report
any irregularities to the attending
doctor and director of nursing.
Thus, specific justification is
required in relation to prescribing of
psychoactive drugs.  The regulations
state that “the resident has the right to
be free from any chemical restraints
imposed for purposes of discipline or
convenience and not required to treat
the resident’s medical symptoms”.
Further regulations provide specific
guidance on the use of unnecessary
drugs and antipsychotic drugs.
benzodiazepines and other anxiolytic/
sedative drugs, drugs for sleep
induction (largely hypnotics) and
miscellaneous agents such as
barbiturates.
In the latter case, it is stated that
the initiation of drugs such as
amobarbital and secobarbital should
not occur in any dose for any resident.
Those patients already receiving these
drugs should undergo a gradual dose
reduction programme.
The regulations provide a wealth of
information on the effective use of
antipsychotic drugs.  Guidance on drug
dosage levels and monitoring for
antipsychotic side-effects is given.  It
is specifically stated that, based on a
comprehensive assessment of a
resident, the facility must ensure that
• Flurazepam
• Chlordiazepoxide
• Clorazepate
• Diazepam
• Clonazepam
• Quazepam
• Halzepam
Table I
Long-acting
benzodiazepines
which should
not be used
in nursing
home
residents
according to
HCFA
regulations3
Antipsychotic drugs should not be
used unless the clinical record
documents that the resident has
one or more of  the following
“specific conditions”
• Schizophrenia
• Schizo-affective disorder
• Delusional disorder
• Psychotic mood disorders
(including mania and
depression with psychotic
features)
• Acute psychotic episodes
• Brief reactive psychosis
• Schizophreniform disorder
• Atypical psychosis
• Tourette’s disorder
• Huntington’s disease
• Organic mental syndromes
(called delirium, dementia and
amnestic and other cognitive
disorders by DSM-IV*) with
associated psychotic and/or
agitated behaviours.
* Diagnostic and Statistical Manual of
Mental Disorders, fourth edition.
Table IIa
Medical conditions in which
antipsychotic agents may be used
as specifically governed by OBRA
87 regulations2
An unnecessary drug is broadly
defined as a drug that is used in
excessive dose, for excessive duration,
without adequate indications for its use
or in the presence of adverse
consequences which indicate the dose
should be reduced or discontinued.
For example, it is stated that specified
long-acting benzodiazepines should not
be used in residents unless an attempt
with a shorter-acting drug has failed;
these long-acting agents are listed in
Table I.
However, exceptions to these
guidelines are made in the case of
diazepam being used for neuromuscular
disorders or when long-acting
benzodiazepines are being used to
withdraw patients from shorter-acting
drugs.  Further guidance is given in
relation to the use of short-acting
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residents who have not used
antipsychotic drugs are not given these
drugs unless antipsychotic drug therapy
is necessary to treat a specific
condition as diagnosed, and
documented in the clinical record and
those who receive these drugs, should
also undergo gradual dose reductions
and behavioural interventions (unless
clinically contra-indicated) in an effort
to discontinue these drugs; the medical
conditions of note are detailed in
Tables IIa and IIb. The aim of this
particular regulation is that the use of
psychoactive medication must be
justified and documented.  Therefore, it
is permissable to prescribe in apparent
contravention of the legislation
provided clinical justification is given.
Lessons for the international
pharmacy profession
Clearly, the provision of
pharmaceutical services to nursing
homes and other long-term care
environments in the USA is markedly
different to that in other parts of the
world.  Consultant pharmacy is
generally perceived as a clinical
speciality, and remuneration for
services is very different to other
national health systems.  Perhaps most
importantly, many countries do not
have a legislative system in place
which demands medication review by a
pharmacist and justification of
prescribing decisions.
Because of these pronounced
differences, the import of a consultant
pharmacy model into other countries
requires considerable discussion and
debate.  Under the current United
Kingdom system, the community
pharmacist’s involvement in clinical
activities to nursing homes is limited
to medication supply.
There is also the potential conflict
of interest in that pharmacists are
currently the main providers of
medication to homes; as they are
remunerated for the number of items
they dispense, there is little incentive
to rationalise medication.  The current
payment available to pharmacists
providing advice to homes would not
compensate for losses incurred through
a reduction in dispensing.
It is also important to consider
those who work within the nursing
home sector.  Although the pharmacy
profession may view an extension of
services and responsibility to be highly
desirable, the views of nursing home
managers and other health care
professionals who work within this
environment should also be sought.  A
recent survey carried out in all nursing
and residential homes in Northern
Ireland indicated that staff in these
homes were highly supportive of
further staff training by pharmacists in
the recognition of medication-related
problems, additional advice and
guidance on missed doses and a
pharmacist review of patient
medication records to assess drug-drug
interactions and possible adverse drug
reactions4.
Long-term care for the elderly is
becoming a major issue within UK
health policy.  The Royal College of
Physicians has commended the role of
community pharmacists in medicines’
Antipsychotics should not be used
if one or more of the following is/
are the only indication
• Wandering
• Poor self care
• Restlessness
• Impaired memory
• Anxiety
• Depression
• Insomnia
• Unsociability
• Indifference to surroundings
• Fidgeting
• Nervousness
• Uncooperativeness
• Agitated behaviours which do
not represent danger to the
resident or others
Table IIb
Medical conditions in which
antipsychotic agents should not be
used as specifically governed by
OBRA 87 regulations2
management as part of its report on
“Medication for Older People”5 and
considers that the profession can
contribute to the care of nursing home
residents.
Most recently, the UK Department of
Health has issued a document entitled
“Care Homes for Older People.  National
Minimum Standards”6.  This outlines
national minimum standards expected
under the Care Standard Act 2000 and
one such standard states that the
registered manager of a home should
seek information and advice from a
pharmacist regarding medicines policies
within the home and medicines
dispensed for individuals within the
home.
The increasing elderly population
represents major challenges for health
care professionals in the new
millennium and pharmacy is no
exception.  Pharmacists need to
examine what they currently do within
long term care and expand their
services accordingly.
The American model is something
from which we can learn, and perhaps
by selecting those elements which are
most adaptable to the other healthcare
systems, we can start to move some
way towards a more holistic approach of
care to a highly vulnerable patient
group. ✱
